Pershing Square Capital Management, L.P.Pershing Square Capital Management, L.P.

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings8 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

CHIPOTLE MEXICAN GRILL INC

953,608$2B18.9%$9.21+358.32%
19 qtrssince 2018-Q4
Decreased
0

RESTAURANT BRANDS INTERN

23.3M$1.8B16.7%$42.95+64.59%
19 qtrssince 2018-Q4
Decreased
0

LOWE'S COS INC

7.5M$1.7B15.6%$82.80+155.52%
19 qtrssince 2018-Q4
Decreased
0

HILTON WORLDWIDE HLDGS

9.3M$1.4B12.6%$70.64+102.31%
19 qtrssince 2018-Q4
Increased
65

HOWARD HUGHES CORPORATION

16.6M$1.3B12.1%
19 qtrssince 2018-Q4
Increased
67

CANADIAN PACIFIC RAILWAY LTD /CAD/

15.1M$1.2B11.3%$78.010.00%
1 qtr
New
100

ALPHABET INC-CL C

9.4M$1.1B10.5%$103.16+15.48%
2 qtrssince 2023-Q1
Increased
75

ALPHABET INC-CL A

2.2M$261.5M2.4%$100.13+18.06%
2 qtrssince 2023-Q1
Unchanged
0
$10.8B
AUM
8
Positions
Q2 2023
Filing
Rating · 1.0
Quarterly Portfolio Change
-12%Q3'21$9.5B+14%Q4'21$10.8B-4%Q1'22$10.4B-28%Q2'22$7.5B+37%Q1'23$10.2B+6%Q2'23$10.8B
Activity profile
$ moved · Q2'23
New34%Increased10%Decreased22%Exited33%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.9 years
<1Q13%1-4Q25%1-2Y0%2Y+63%

Pershing Square Capital Management, L.P. manages $10.8B across 8 positions as of Q2 2023. Top holdings: CMG (18.9%), QSR (16.7%), LOW (15.6%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1/5.0.

Q2 2023 Summary

Added 1 new position, exited 1, increased 3, trimmed 3. Top move: CP (NEW, conviction 100). Portfolio: $10.8B across 8 positions.

Top holdings by portfolio weight

Total AUM$11B
CMG18.86%
QSR16.73%
LOW15.58%
HLT12.56%
HHC12.09%
CP11.27%
GOOG10.49%
GOOGL2.42%
CANADIAN PAC0.00%

Portfolio allocation by GICS sector

Sectors4
Consumer Cyclical63.73%
Communication Services12.91%
Unknown12.09%
Industrials11.27%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Consumer Cyclical, Communication Services, Unknown
Compare DNA across all funds
7-dimension quality assessment
Weak(1.0 / 5.0)
Track RecordNo data
Conviction46
Concentration0
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
AMZNAMZNAMAZON.COM INC
Q4 2025 Q1 2026+5.6M shares+$1.1B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used